Genelux Corp Files 8-K Report
Ticker: GNLX · Form: 8-K · Filed: Apr 2, 2024 · CIK: 1231457
| Field | Detail |
|---|---|
| Company | Genelux Corp (GNLX) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC filing, regulatory-disclosure
Related Tickers: GENL
TL;DR
GENELUX filed an 8-K, standard reporting stuff.
AI Summary
On April 1, 2024, Genelux Corporation filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it confirms the company's reporting status.
Why It Matters
This filing indicates that Genelux Corporation is meeting its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report, not indicating any immediate material changes or risks.
Key Players & Entities
- Genelux Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 2625 Townsgate Road, Suite 230 (address) — Principal executive offices
- Westlake Village, California (location) — City and State of principal executive offices
- 91361 (zip_code) — Zip code of principal executive offices
- (805) 267-9889 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Genelux Corporation?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on April 1, 2024.
In which state is Genelux Corporation incorporated?
Genelux Corporation is incorporated in Delaware.
What is the business address of Genelux Corporation?
The business address of Genelux Corporation is 2625 Townsgate Road, Suite 230, Westlake Village, California, 91361.
What is the telephone number for Genelux Corporation?
The telephone number for Genelux Corporation, including area code, is (805) 267-9889.
Filing Stats: 546 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-04-01 18:37:32
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 per share GNLX The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 32KB
- ex99-1_001.jpg (GRAPHIC) — 305KB
- ex99-1_002.jpg (GRAPHIC) — 590KB
- ex99-1_003.jpg (GRAPHIC) — 239KB
- ex99-1_004.jpg (GRAPHIC) — 329KB
- ex99-1_005.jpg (GRAPHIC) — 331KB
- ex99-1_006.jpg (GRAPHIC) — 295KB
- ex99-1_007.jpg (GRAPHIC) — 279KB
- ex99-1_008.jpg (GRAPHIC) — 300KB
- ex99-1_009.jpg (GRAPHIC) — 258KB
- ex99-1_010.jpg (GRAPHIC) — 315KB
- ex99-1_011.jpg (GRAPHIC) — 317KB
- ex99-1_012.jpg (GRAPHIC) — 333KB
- ex99-1_013.jpg (GRAPHIC) — 380KB
- ex99-1_014.jpg (GRAPHIC) — 365KB
- ex99-1_015.jpg (GRAPHIC) — 246KB
- ex99-1_016.jpg (GRAPHIC) — 350KB
- ex99-1_017.jpg (GRAPHIC) — 358KB
- ex99-1_018.jpg (GRAPHIC) — 301KB
- ex99-1_019.jpg (GRAPHIC) — 229KB
- ex99-1_020.jpg (GRAPHIC) — 348KB
- ex99-1_021.jpg (GRAPHIC) — 322KB
- ex99-1_022.jpg (GRAPHIC) — 265KB
- ex99-1_023.jpg (GRAPHIC) — 266KB
- ex99-1_024.jpg (GRAPHIC) — 277KB
- ex99-1_025.jpg (GRAPHIC) — 309KB
- ex99-1_026.jpg (GRAPHIC) — 289KB
- ex99-1_027.jpg (GRAPHIC) — 194KB
- ex99-1_028.jpg (GRAPHIC) — 328KB
- ex99-1_029.jpg (GRAPHIC) — 312KB
- ex99-1_030.jpg (GRAPHIC) — 261KB
- ex99-1_031.jpg (GRAPHIC) — 240KB
- ex99-1_032.jpg (GRAPHIC) — 306KB
- ex99-1_033.jpg (GRAPHIC) — 327KB
- ex99-1_034.jpg (GRAPHIC) — 340KB
- ex99-1_035.jpg (GRAPHIC) — 264KB
- ex99-1_036.jpg (GRAPHIC) — 358KB
- ex99-1_037.jpg (GRAPHIC) — 450KB
- ex99-1_038.jpg (GRAPHIC) — 356KB
- ex99-1_039.jpg (GRAPHIC) — 339KB
- 0001493152-24-012563.txt ( ) — 17144KB
- gnlx-20240401.xsd (EX-101.SCH) — 3KB
- gnlx-20240401_lab.xml (EX-101.LAB) — 33KB
- gnlx-20240401_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Genelux Corporation Date: April 1, 2024 By: /s/ Thomas Zindrick, J.D. Thomas Zindrick, J.D. President and Chief Executive Officer